tiprankstipranks
Trending News
More News >
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
US Market
Advertisement

Amneal Pharmaceuticals (AMRX) Ownership - Who Owns Amneal Pharmaceuticals?

Compare
555 Followers

Amneal Pharmaceuticals (AMRX) Ownership Overview

41.01%9.83%13.00%9.79%26.37%
41.01% Insiders
13.00% Other Institutional Investors
9.79% ETFs
26.37% Public Companies and
Individual Investors
The ownership structure of Amneal Pharmaceuticals (AMRX) stock is a mix of institutional, retail, and individual investors. Approximately 32.62% of the company’s stock is owned by Institutional Investors, 41.01% is owned by Insiders, and 26.37% is owned by Public Companies and Individual Investors.
The ownership structure of Amneal Pharmaceuticals (AMRX) stock is a mix of institutional, retail, and individual investors. Approximately 22.82% of the company’s stock is owned by Institutional Investors, 41.01% is owned by Insiders, and 9.79% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 25, 2025
xxxxxxxxxxxxx
$1166223
Aug 22, 2025
xxxxxxxxxxxxx
$2619309
Aug 15, 2025
xxxxxxxxxxxxx
$666037
Aug 15, 2025
xxxxxxxxxxxxx
$4663070

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$207759
Jun 30, 2025
xxxxxxxxxxxxx
$490035

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
48,578,209Insider15.47%459,064,075
26,856,413Insider8.80%253,793,103
25,617,285Insider8.16%242,083,343
22,127,400Insider7.05%209,103,930
16,465,712Institution5.24%155,600,978
13,620,287Institution4.34%128,711,712
6,252,191Institution1.99%59,083,205
2,409,460Institution0.77%22,769,397
1,903,649Institution0.61%17,989,483
1,738,151Institution0.55%16,425,527

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
13,620,287Institution4.34%128,711,712
2,409,460Institution0.77%22,769,397
1,903,649Institution0.61%17,989,483
1,738,151Institution0.55%16,425,527
1,585,892Institution0.50%14,986,679
1,121,364Institution0.36%10,596,890
982,236Institution0.31%9,282,130
947,126Institution0.30%8,950,341
814,311Institution0.26%7,695,239
438,076Institution0.14%4,139,818

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,608,382Institution1.79%43,857,547
4,196,126Institution1.34%32,813,705
3,621,361Institution1.15%34,221,861
2,697,863Institution0.86%21,097,289
1,627,376Institution0.52%12,726,080
1,149,667Institution0.37%10,864,353
977,883Institution0.31%9,182,321
850,430Institution0.27%8,036,564
717,388Institution0.23%5,609,974
713,222Institution0.23%6,697,155

FAQ

Who Owns Amneal Pharmaceuticals Inc (AMRX)?
According to the latest TipRanks data, approximately 13.00% of the company's stock is held by institutional investors, 41.01% is held by insiders, and 26.37% is held by retail investors.
    What percentage of Amneal Pharmaceuticals Inc (AMRX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 13.00% of Amneal Pharmaceuticals Inc (AMRX) stock is held by institutional investors.
      What percentage of Amneal Pharmaceuticals Inc (AMRX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 26.37% of Amneal Pharmaceuticals Inc (AMRX) stock is held by retail investors.
        Who owns the most shares of Amneal Pharmaceuticals Inc (AMRX)?
        Tushar Bhikhubhai Patel owns the most shares of Amneal Pharmaceuticals Inc (AMRX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis